January 7, 2019 - Page 27 of 31

NASDAQ Companies - January 7, 2019

Chembio Diagnostics Receives CE Mark for Point-of-Care Diagnostic Test Developed in Collaboration with AstraZeneca

MEDFORD, N.Y., Jan. 07, 2019 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on […]

NASDAQ Companies - January 7, 2019

NeuroMetrix Adds Artificial Intelligence, Coaching and New Therapy Option to Quell 2.0 For Personalized Pain Relief

The smart wearable harnessing the power of neurostimulation and AI to attack the chronic pain crisis LAS VEGAS, Jan. 07, […]

NASDAQ Companies - January 7, 2019

ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Leber’s Congenital Amaurosis 10

LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing […]

NASDAQ Companies - January 7, 2019

Amicus Therapeutics Provides Full-Year 2019 Strategic Outlook and Financial Guidance

Full-Year 2018 Galafold Revenue of ~$91M Exceeds $80M-$90M Guidance 2019 Galafold Revenue Expected to Nearly Double – with Guidance of […]

NASDAQ Companies - January 7, 2019

Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial

LIQ861 was well-tolerated in PAH patients at two-weeks of treatment, the safety endpoint requested by U.S. FDA NDA submission targeted […]

NASDAQ Companies - January 7, 2019

SI-BONE Reports Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018

SANTA CLARA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that pioneered the […]

NASDAQ Companies - January 7, 2019

ContraFect’s Exebacase (CF-301) Improved Clinical Outcomes in Staphylococcus aureus Bacteremia including Right-Sided Endocarditis Compared to Standard of Care Antibiotics Alone in a First-in-Patient Phase 2 Superiority Study

Proof of concept that new class of lysin biologics has the potential to improve treatment outcomes in serious bacterial infections […]

NASDAQ Companies - January 7, 2019

Microbot Medical Announces FDA Pre-Submission Milestones for 2019

Regulatory Pre-Submission of the Self-Cleaning Shunt (SCS™) Remains the Primary Operational Objective HINGHAM, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) — […]

NASDAQ Companies - January 7, 2019

Verrica Appoints Neil D. DeHenes as Vice President of Distribution, Trade and Channel Strategy

WEST CHESTER, Pa., Jan. 07, 2019 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on […]

NASDAQ Companies - January 7, 2019

Guardant Health Announces Launch of the LUNAR Assay for Detection of Early-Stage Cancer and Recurrence to Academic and Biopharmaceutical Researchers

REDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) — The LUNAR assay, a new blood-based assay intended to detect early-stage […]